Position Statement: Protecting Human Rights and Travel Freedom for Cancer Patients and their Families, Researchers and Providers of Cancer Care

Authored by the IPOS Human Rights Task Force

Released: March 7, 2017

The International Psycho-Oncology Society (IPOS) is committed to the wellbeing and quality of life of cancer patients and survivors and their families worldwide. Therefore, IPOS advocates for humane physical and emotional care for refugees and immigrants worldwide without discrimination, as provided for in the Geneva Convention, especially those with cancer.

Given our organization’s focus on the well-being of cancer patients everywhere, we recognize the necessity for pediatric and adult cancer patients to travel freely to access medical, psychosocial and supportive care and for caregivers to travel freely to provide support for ill patients and other family members. When treatment is no longer effective, we recognize the right of every individual to palliative care and dying with dignity and the right of the loved ones to gather to honor and mourn their losses.

IPOS also supports international efforts to train health care providers in clear communication with patients and family members, support for shared decision-making and consideration of cancer patients’ states of distress and psychosocial needs. Freedom for researchers and care providers to acquire appropriate training, to work collaboratively in advancing care of cancer patients and to share ideas at international conferences is crucial to the rapid dissemination of research findings and progress in cancer care. Hence, IPOS strongly condemns the emergence of unjust and discriminatory policies which erect barriers that unnecessarily disrupt and disrespect the lives of many innocent people, among them, refugees from states with civil unrest, migrants needing cancer care, caregivers, and researchers and educators working to find cancer cures and to improve human health and well-being. These policies undermine the sense of community and collaboration which drives progress internationally. We encourage others to join us in sharing the responsibility of civil societies to protect those whose lives are made vulnerable by illness of any sort, by social unrest, poverty, or war.

Founded in 1984, the International Psycho-Oncology Society (IPOS) was created to foster international multidisciplinary communication about clinical, educational and research issues that relate to the subspecialty of psycho-oncology and two primary psychosocial dimensions of cancer:

  1. Response of patients, families and staff to cancer and its treatment at all stages
  2. Psychological, social and behavioral factors that influence tumor progression and survival.

Early Career Professionals Conference Scholarships available!

Due to a grant from the KARL-HEINZ FRENZEN-STIFTUNG we are able to waive early bird conference fees for 12 Early Career Professionals in Psycho-Oncology (ECPP) from low and middle income countries (LMI) who actively participate at the IPOS 2017 Berlin conference (abstract submission). For a list of LMI countries, please visit: http://chartsbin.com/view/2438.

Who is an Early Career Professionals in Psycho-Oncology (ECPP)? Researchers who are up to 3 years post final qualification or training.

The application process: To apply, please submit an application form by 15th March 2017. If you are eligible, your application will be forwarded to the ECPP SIG and the Education committee for review. Successful applicants will be notified by email by before the 15th April.

Scholarship application form: Please complete the form and submit to [email protected] BEFORE 15th March 2017!

Preference will be given to current IPOS members that hold anEarly Career Professional Membership” type of membership. Membership is $25 US per year. Details on membership can be found by going to http://ipos-society.org/apply/.

WHO announces a renewal of IPOS’ status as an official non-state actor fostering our commitment to global standards for quality care for cancer patients

The International Psycho-Oncology Society (IPOS) is pleased to report that the World Health Organization (WHO) has renewed our status as an official non-state actor. To achieve such status, IPOS is continuing to be recognized as a significant global health resource in advocating, promoting and protecting public health.

To become an official WHO non-stator actor, IPOS had to meet set criteria and principles. These were:

  • Geographical representation and equitable distribution/promotion
  • Technical expertise
  • Transparency
  • Effective governance
  • Public announcements/outreach

Information about WHO and official non-state actors can be view by going to http://who.int/about/collaborations/non-state-actors/en/

For WHO, IPOS has been listed as:

International Psycho-Oncology Society. Collaboration on psychosocial oncology for supportive care for cancer patients including palliative care to support capacity-building in low- and middle-income countries and areas through educational programmes. The primary focus is to improve standards of palliative and supportive care and assist in the development of skilled health care services with the capacity to deliver improved standards and develop in-country systems and training processes in palliative and supportive care for cancer patients.

IPOS would like to thank our WHO committee for all their work ensuring our relationship is renewed with WHO.

NEW IPOS MEMBER BENEFIT – Introducing the Sosido Network for IPOS members

We’re pleased to announce that IPOS is participating in the online knowledge sharing network Sosido (www.sosido.com). IPOS joins a growing network of associations and research groups on Sosido.

IPOS members will receive:

  • A weekly email digest summarizing all activity in the IPOS community. You don’t have to log in to participate, and anything that’s important will come to your inbox, including:
  • Updates on all publications authored by IPOS members that week. Sosido automatically delivers a current and complete snapshot of the work of our IPOS community.
  • A summary of new articles released that week from journals chosen by you.
  • Access to a secure IPOS members-only forum to ask and answer questions.
  • Members can unsubscribe from emails or remove yourself from the network at any time.

Watch a 2-minute video introduction to Sosido.

Note – you must maintain a current IPOS membership to take advantage of this new IPOS member benefit. If you have not already, please activate your IPOS membership for 2017 by going to http://www.karelo.com/register.php?BID=618&BT=10&Ev=16772

IPOS is now accepting new members and renewals for 2017

IPOS is now accepting new members and renewals for 2017.

IPOS Membership is based on a calendar year — membership is only valid from the time of application through 31 December of the same year. Renewal invoices are distributed at the end of each calendar year for the next year’s dues.

For information on membership categories and pricing, please go to http://www.ipos-society.org/for-members/membership-classifications/

To apply for IPOS Membership:

    1. Review IPOS Member Benefits.
    2. Determine which Membership Classification suits your professional experience and location.
    3. Click here to join or renew your 2017 IPOS membership online.
    4. Click here and complete the 2017 Membership Application to apply via fax or mail.

Not sure if you have joined or renewed for 2017 yet? Please email the IPOS office and we will confirm.

 

ipos-membership-flyer-20172

MIND AND EMOTIONS IN CANCER: STUDIES FROM DEVELOPING COUNTRIES

Guest Editor: IPOS Board member Csaba Dégi PhD, MSW

MIND AND EMOTIONS IN CANCER: STUDIES FROM DEVELOPING COUNTRIES

COGNITION, BRAIN, BEHAVIOR. AN INTERDISCIPLINARY JOURNAL
Indexed in PsychInfo, IBSS, Scopus, EBSCO and ProQuest
Published by the Romanian Association for Cognitive Sciences
http://www.cbbjournal.ro/

http://www.psychooncology.ro/mind-and-emotions-in-cancer-studies-from-developing-countries/

Update from the Psycho-Oncology Journal Editors: Plans for 2017

ipospo

 

 

2017 is an exciting year for the Psycho-oncology journal. It is the 25th anniversary for the journal which has come of age. As Editors, we want to express our gratitude to the many authors, reviewers and readers who have made it happen. Your continued support for Wiley and us has been unwavering and an important component in our success. To mark this occasion we want to give an update and tell you about some innovations.

CHALLENGES in PSYCHO-ONCOLOGY SERIES.

Beginning in 2017, invited Commentaries will be published to highlight new issues in oncology which have psychosocial and behavioral ramifications. Invited authors for each Commentary will include internationally known oncologists and psycho-oncologists. The first of the Series will be New Challenges in Precision Medicine in which communication is a major concern and delay in end of life discussions. Other New Challenges topics being considered are Challenges in Psycho-neuro-immunology Research in Cancer; in Survivorship; in Depression and Cancer Research. By introducing this series the aim is to make important links across the disciplines which emphasize the multi-disciplinary care concepts.

AFFILIATE BOARD.

In 2016 we introduced a radical change to the editorial board structure. In order to engage junior and middle level investigators in the journal, earlier in their career, we established this Affiliate Board to bring in ideas from junior faculty. Affiliate Board Members and their countries of origin are:

Cris Decat Bergerot (Brazil), Pernille Envold Bidstrup (Denmark), Csaba Dégi (Romania), Jayita Deodhar (India), Wendy Lam (Hong Kong, China), Sokhna Ndiaye (Senegal), Ying Pang (China), Errol Philip (USA), Natalia Rivkina (Russia), Sigrun Vehling (Germany), Claire Wakefield (Australia), Katriina Whitaker (UK).

EDITORIAL BOARD.

The senior Board has been reviewed and efforts made to diversify the international representation further with additional psycho-oncology professionals from Lower and Middle Income countries. More manuscripts are coming from these countries and we try to nurture scholarship there by encouraging and supporting young investigators. The growing strength of psycho-oncology in Asia is impressive and the number of board members from this area has been increased. For full details please see journal website [http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1611/homepage/EditorialBoard.html].

REWARDING REVIEWERS: WILEY’S PARTNERSHIP WITH PUBLONS.

Wiley has partnered with Publons to give you official recognition for your contribution to peer review. Publons helps you to record, verify, and showcase your peer review contributions for use in promotion and funding applications. When you review for Psycho-Oncology, you can opt in to get credit on Publons. For further information on Wiley’s partnership with Publons, please visit https://publons.com/in/Wiley/

SPECIAL TOPIC ISSUES.

We welcome suggestions of topics for a Special Issue—an emerging topic that should be covered in more detail. A MONTHLY NEWSLETTER to both Boards is under consideration as a possible vehicle for greater and more rapid sharing of ideas and implementation of them.

The Editors welcome your thoughts about 2017 and gratefully thank you for your participation and support for the journal.

For further information and comments please contact the Editors by email.

[email protected]

[email protected]

 

 

Jeff Dunn – the IPOS Board representative in UICC – organised a psycho-oncology symposium at the recent World Cancer Congress in Paris

unknownJeff Dunn – the IPOS Board representative in UICC – organised a psycho-oncology symposium at the recent World Cancer Congress in Paris. This was very well attended by delegates from a range of disciplines with standing room only.

The session highlighted issues in psycho-oncology care that IPOS strives to bring to multidisciplinary audiences.

All with due thanks to Professor Dunn.

dunn

IPOS standard at BCY3 guidelines

Dear Colleagues

I was invited to participate at the 3rd ESO-ESMO Breast Cancer in Young Women International Conference in Lugano, Switzerland, to present Psycho-oncology issues at the Survivorship session.

fullsizerender

Recently I participated at the panel of experts for the clinical guidelines of the treatment of young women with breast cancer. I was able to place our standard in the guidelines as you can see in the attached photo, which was unanimously voted for ‘approve’ by the panel!

A small step but which hopefully will make a big difference in the near future for the treatment and care these group of patients!

The guidelines will be published soon.

I will keep you posted.

All my best,

luzia-travado
President, IPOS
Luzia Travado PhD
Portugal (2014-2017)

Prostate Cancer Units Network – Free Membership

cartolina-a5-pcu-21-jan2